Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7491

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7491). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B7d001ec 189e 4275 8f67 Dc399d23bb1c 01)

Image (B7d001ec 189e 4275 8f67 Dc399d23bb1c 01)
Chemical structure of rosuvastatin calcium showing its molecular arrangement including fluorophenyl, sulfonamide, and calcium ion components, corresponding to the active ingredient rosuvastatin calcium.*
FDA Label Image

Image (B7d001ec 189e 4275 8f67 Dc399d23bb1c 02)

Image (B7d001ec 189e 4275 8f67 Dc399d23bb1c 02)
A line graph showing cumulative incidence percentages over time in years, comparing Rosuvastatin Calcium (Rosuva) with placebo. The graph includes data points on the number of subjects at risk for each group at different time intervals, with Rosuvastatin showing a lower cumulative incidence compared to placebo.*
FDA Label Image

Image (B7d001ec 189e 4275 8f67 Dc399d23bb1c 03)

Image (B7d001ec 189e 4275 8f67 Dc399d23bb1c 03)
A forest plot chart showing hazard ratios and 95% confidence intervals for various cardiovascular endpoints comparing Rosuva 20 mg versus placebo 20 mg. The endpoints include cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), hospitalized unstable angina, and arterial revascularization, with corresponding event rates and hazard ratios.*
FDA Label Image

Image (B7d001ec 189e 4275 8f67 Dc399d23bb1c 04)

Image (B7d001ec 189e 4275 8f67 Dc399d23bb1c 04)
A box plot chart comparing percent change from baseline in LDL cholesterol (LDL-C) for four drugs: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The x-axis shows drug doses in mg, with Rosuvastatin doses at 10, 20, and 40 mg, and other drugs at various doses up to 80 mg. The y-axis represents percent change from baseline in LDL-C, ranging from -75% to 0%. The data illustrate LDL-C reduction variability across doses and drugs.*
FDA Label Image

Label Image (Lbl500907491)

Label Image (Lbl500907491)
Rosuvastatin Calcium 5 mg film-coated tablets label from A-S Medication Solutions. The label includes the product name, dosage strength, quantity of 90 tablets, storage instructions to store at 68 to 77 degrees Fahrenheit and protect from moisture, along with the product NDC 50090-7491-0. It also mentions the USP equivalent of Rosuvastatin Calcium and packaging information with a Dosage barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.